[Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].

Abstract excerpt

Mutations of the bone morphogenetic protein receptor II gene (BMPR2) have been reported in patients with pulmonary arterial hypertension (PAH). In hereditary hemorrhagic telangiectasia (HHT) patients with PAH, missense mutations of the activin receptor-like kinase 1 gene (ALK1) located in the serine-threonine kinase domain. Recently, the mutations of ALK1 in the serine-threonine kinase domain were observed in PAH...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Activin Receptors, Type I
• Share to Bone Morphogenetic Protein Receptors, Type II